Surgery of Intramedullary Tumors

Published on 02/04/2015 by admin

Filed under Neurosurgery

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3049 times

Chapter 30 Surgery of Intramedullary Tumors

INTRODUCTION

Intramedullary spinal cord tumors are rare, accounting for about 4–10% of all central nervous system tumors. Astrocytomas and ependymomas are the most commonly encountered spinal intramedullary tumors, and are found in up to 70% of all spinal intramedullary tumors. Most intramedullary cord tumors are benign gliomas. The determination of the optimum treatment of these tumors is controversial. In the past, there has been the traditional approach of biopsy, dural decompression, and radiation therapy, despite the recognition that after a relatively short remission, progression ensues, and the patient quickly becomes seriously disabled. This treatment was based on the assumption that astrocytomas are infiltrative tumors and that radical resection poses a high probability of inflicting neurological injury to the patient. These assumptions are debatable because most of these neoplasms are low-grade lesions. Recent advances in microsurgical technology, such as the ultrasonic aspirator, laser, intraoperative ultrasound, and intraoperative neurophysiological monitoring, permit a safer aggressive surgical resection. A radical surgical approach for intramedullary spinal cord tumor has been proposed by some surgeons. The radical resection without adjuvant treatment has been the rule for the intramedullary lesions.1 The postoperative functional performance is determined mainly by the preoperative deficits. The rate of aggravation is less than 20%. The most influencing prognostic factor for the postoperative result is the extent of tumor removal.2 The goal of surgery is maximal removal of the tumor mass without additional functional deficits.

SURGICAL TECHNIQUES OF INTRAMEDULLARY CORD TUMOR RESECTION

IDENTIFICATION OF MIDLINE

There are two routes to intramedullary tumors: through the posterior midline or through a posterolateral myelotomy through the root entry zone.4 The former follows the posterior median sulcus, and the spinal cord is split between the two posterior columns.

The midline of the spinal cord is anatomically identified with branches of the dorsal medullary vein penetrating the median sulcus. The thin membrane from the arachnoid attaches to the dorsal midline surface of the spinal cord (area posticum). Sometimes a spinal cord edema makes it difficult to identify the midline on the posterior surface of the spinal cord. The vessels usually are located off midline and do not constitute reliable markers. If the anatomical midline is not definite, the imaginary line is assumed from the bilateral dorsal root entry zone. The tumor-infiltrated spinal cord possesses a swollen appearance.5 In cases of a hypervascular mass or tumor hemorrhage, the bluish discoloration is seen through the surface of the spinal cord6 (Fig. 30-1).

The posterolateral approach offers a lateral route where the posterior roots enter the spinal cord. The spinal cord is opened through the dorsal root entry zone (DREZ) between two or more roots. This route offers an avenue for resecting intramedullary lesions that is off the midline and closer to the lateral surface of the spinal cord. This approach can be applied to the astrocytoma or cavernous hemangioma. A myelotomy should be chosen based on the patient’s symptoms and MRI findings.

MYELOTOMY

The myelotomy can be performed with a No. 11 blade, a No. 59 beaver-blade, a CO2 laser, or a neodymium:yttrium-aluminum garnet (Nd-YAG) contact laser.4 Some surgeons routinely use the latter during myelotomy. Compared with electrocauterization, this technique causes no artifact during electrophysiological monitoring.

Postoperatively, patients may complain of transitory dysesthesia or of diffuse, ill-defined sensory symptoms. The symptoms are caused by microvascular damage to the posterior columns during the myelotomy.

After midline identification, the small pial vessels crossing the midline are coagulated. The large vessels, running longitudinally along the pial surface, should be saved with dissection. Pial incision starts from the maximum enlargement area of the spinal cord, extending to the cephalocaudal margin of the tumor mass. The midline myelotomy is performed using a fine arachnoid knife. Careful dissection is imperative.

When the length of the myelotomy falls short, the resection margin cannot be identified. Discontinuous myelotomy is a viable technical option whenever the presence of large vessels on the median sulcus would make the standard midline myelotomy unsafe. After a small incision is made, the median sulcus is gently spread with the aid of microdissectors or microforceps to deepen the myelotomy until the tumor’s pole or cyst is exposed or opened both rostrally and caudally. The interface of the median sulcus usually can be identified by small vessels running over its surface, even if the midline has deviated to either side as a result of tumor compression (Fig. 30-2).

The mass is encountered about 2 cm deep from the surface. The whole length of the mass is exposed, then the incision margin of the pia is sutured with a fine 6-0 or 7-0 nylon to the reflected dura. The spinal cord tissue over the tumor mass is retracted to expose the tumor mass (Fig. 30-3).

A sufficiently long myelotomy should be made over the extension of the tumor mass to avoid traction injury. The middle of the tumor is first dissected from each of its lateral margins, and a dissection plane between the tumor and normal tissue is confirmed on the basis of intraoperative microscopic observation of color and tissue consistency. The dissection plane is then extended bilaterally toward the rostral and caudal ends. Further dissection is repeated longitudinally into deeper regions. A deeper dissection of the lateral margin of the tumor may injure the corticospinal and lateral spinothalamic tracts.

Once the rostral or caudal pole of the tumor is freed, the tumor is lifted with tumor forceps, and the ventral side of the tumor is gently dissected from the spinal cord. In this way, en bloc removal is attempted. The bleeding from the surface of the tumor-dissected plane usually stops by itself, or it can be stopped with Surgicel, avoiding bipolar coagulation.

If no plane is apparent between the tumor mass and the surrounding spinal cord, then it is likely that an infiltrative tumor is present. A biopsy specimen is first obtained to confirm a pathological diagnosis.

DISSECTION OF THE TUMOR MASS

Astrocytoma

The astrocytoma is dark red. The dorsal part of the mass shows relatively good demarcation. However, as the dissection proceeds ventrally, the infiltration of mass to surrounding tissue becomes definite. Dissection on the surface of an astrocytoma usually results in the development of laminated pseudo-planes (Fig. 30-7). Decompression is achieved with an ultrasonic aspirator and proceeds systematically from the center of the tumor radially to the surface. All aspects of the removal procedure should be carried out using spinal evoked potentials and motor stimulation. Although a clean plane does not exist for the majority of astrocytomas, there is often a difference in the color and consistency of the tumor with respect to the spinal cord. The tumor mass is darker and tougher than normal cord tissue. The resection begins within the tumor and proceeds to the periphery (centrifugal resection) until normal tissue is reached.

After internal decompression, dura closure is usually performed with the patch to maximize the subarachnoid space.

Hemangioblastoma

All tumors are located on the dorsal or dorsolateral surface of the spinal cord, and a conventional midline myelotomy is not required for exposure.7 After the dural opening, the tumor mass with dilated vessels is identified (Fig. 30-8). The arachnoid is sharply dissected from the surface of the hemangioblastoma and associated vessels. In general, the tumor is approached like an arteriovenous malformation, with special attention to feeding and draining vessels.8

Pial vessels crossing the margin of the tumor at its junction with the pia mater are coagulated using bipolar cautery at a low setting and sharply divided to clearly expose the margin of the tumor at the pial surface. Sensory rootlets embedded into the tumor may be dissected free or interrupted if the tumor is to be completely resected.

The feeding artery is manipulated before the draining vein. Cauterization of the surface tumor vessels is followed by a circumscribing incision around the pial base.

The plane of dissection is developed in a circumferential manner using bipolar cautery, microscissors, and small cottonoid strips. The tumor capsule is normally prominent. It is important that dissection is performed in a completely bloodless field so that each feeding/draining vessel can be distinguished from en passant vessels and interrupted as it reaches the surface of the tumor capsule. Traction on the spinal cord or “tenting” should be avoided while reflecting the poles of the tumor.

Tumor removal is facilitated by excision of the pial attachment as part of the tumor mass. The buried portion of the tumor within the spinal cord is dissected and delivered with traction on the pial base (Fig. 30-9). Occasionally the presence of stained gliotic tissue surrounding the tumor can make it difficult to identify the interface between the tumor and the spinal cord. Despite preoperative embolization, the continuous oozing after penetration is very disturbing when operating under microscope.

Internal decompression should not be performed because it results in severe tumor bleeding.9 Cautery on the tumor surface, however, usually shrinks it to a manageable size.

Bipolar electrocautery must be used carefully and at a low voltage to prevent thermal injury to adjacent neural tissue. If bleeding occurs from the tumor capsule, coagulation often makes it worse. Hemostasis can be obtained by the application of a variety of hemostatic agents such as gel foam soaked in thrombin.

Cavernous Hemangioma

Cavernous hemangioma is the well-delineated lesion composed of abnormal microvessels without the inner normal neural tissue.10 The lesion shows mixed signal intensity on T1- and T2-weighted magnetic resonance imaging (MRI) with a surrounding low signal ring, which denotes hemosiderin ring deposition (Fig. 30-10). The typical appearance of a cavernous malformation is an inhomogeneous high-intensity signal on both T1- and T2-weighted images with a “dark” ring of hemosiderin surrounding and appearing hypo-intense on T1 and T2 weighting. Enhancement is not typical for cavernous malformations.4

Cavernous hemangiomas are described on gross finding as soft and spongy with a dark-blue to red-brown hue. Cavernous malformations are usually well-circumscribed, and a hemosiderin staining of the surrounding tissues caused by repeat bleeding can clearly define the plane of dissection. This discoloration is sometimes the only visual clue by which a cavernous malformation may be detected under the pial surface (Fig. 30-11). After the dural incision, the surface of the spinal cord appears swollen and of a dark red color. The myelotomy is performed on the midline or discolored portion. The myelotomy should be parallel to fiber tracts on the long axis of the spinal cord to minimize damage. In most cases, the dissection between the cavernoma and surrounding cord tissue can be accomplished without difficulty because there is a gliotic plane or hematoma (Fig. 30-12). Tongue-like extensions of the cavernous malformation can extend into the surrounding gliotic plane; this should be kept in mind during resection of the cavernous malformation to achieve complete excision. The resection of the lesion is performed using microcurettes and gentle suction aspiration. Handheld suction devices with thumb apertures offer controlled suction strength, which is critical to avoid damaging surrounding tissues. Typically, lesions will be removed in a piecemeal fashion, although some can be resected en bloc. Bleeding is seldom a problem with cavernous malformations because of their low-flow nature, and hemostasis should be accomplished using hemostatic agents and gentle compression. Venous draining anomalies are often associated with cavernous malformations and should be preserved because they may provide venous drainage for adjacent eloquent tissues. After hemostasis is obtained, careful inspection of the resection bed under high magnification is imperative to identify and further resect small “tongues” of cavernous malformation that may extend into the adjacent tissue.8 Incompletely resected lesions can recur and hemorrhage; therefore every attempt should be made to resect these lesions fully during the first surgery.

The pathophysiology of bleeding in the cavernous hemangioma is suggested in three ways.10,11 The first is the perilesional slow oozing of red blood cells through the cavern without significant bleeding, which causes a hemosiderin ring. The second is the intralesional hemorrhage (microhemorrhage) which can grow. The third is the overt and gross hemorrhage which can compress the surrounding neural tissue.

CASE ILLUSTRATION

CASE I

A 37-year-old male patient presented with right upper extremity paresthesia that had persisted for 5 years. On a preoperative imaging study, a well-enhancing cord mass was detected at the C7–T1 level (Fig. 30-13). On a T2-weighted image, the black signal void was seen in the tumor mass, and the dissection plane could be found between the tumor mass and the spinal cord tissue (Fig. 30-14). With this finding, the surgeons expected that the tumor location was extramedullary or near the surface if it was an intramedullary lesion. On an axial cut, the tumor mass occupied the whole cord area without identifiable cord tissue (Fig. 30-15).

An angiogram showed that the tumor feeding vessel arose from the right costocervical trunk. After embolization, the tumor stain disappeared (Figs. 30-16 and 30-17).

A total laminectomy was performed from C6 to T1. After the dural opening, the reddish mass was seen on the posterior surface of the spinal cord (Fig. 30-18). The mass was covered with arachnoid and pia mater. After arachnoid dissection, tortuous surface vessel was seen (Fig. 30-19). A pial dissection and retraction were performed. The interface between the tumor mass and surrounding cord tissue was relatively definite. The dissection plane could be found easily, and an en bloc removal was possible (Fig. 30-20). The gliotic plane was observed after tumor mass removal.

The postoperative MRI showed that no enhancing lesion surrounded the syrinx cavity (Fig. 30-21).

CASE II

A 42-year-old female patient had suffered from posterior neck pain for 5 years and had developed clumsiness in both hands 5 months before being seen at the hospital. She complained of difficulty in walking for a long time. A neurological examination found her to be slightly quadriparetic. Sensory function was seen to be decreased in both hands. An MRI scan was recommended. It showed a well-enhancing mass lesion at the C3–7 region (Fig. 30-22). The mass accompanied a cystic lesion on the cephalad side of the solid mass. The spinal cord was swollen (Fig. 30-23). The surrounding normal spinal cord tissue was so thin that the surgeons could not identify the thickness. The operation was performed via the posterior approach. A total laminectomy was performed from C2 to C6. The laminectomy level was determined by the length of the tumor mass, including the cystic portion.

After the laminectomy and dural incision, the swollen spinal cord was exposed. A midline myelotomy was performed after the midline was determined as the imaginary line between both dorsal root entry zones. The tumor mass was found 2 mm deep into the myelotomy. The tumor dissection was performed with relative ease. Total removal was possible with the ventral cord tissue left intact. The cystic portion showed no lining tissue, which indicated that it was only a syrinx cavity. A postoperative MRI 6 months later found no enhancing dot and the cyst had collapsed (Fig. 30-24).

REFERENCES

1 Kyoshima K, Akaishi K, Tokushige K, et al. Surgical experience with resection en bloc of intramedullary astrocytomas and ependymomas in the cervical and cervicothoracic region. J Clin Neurosci. 2004;11:623-628.

2 Constantini S, Miller DC, Allen JC, et al. Radical excision of intramedullary spinal cord tumors: Surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg. 2000;93(2 suppl):183-193.

3 Parsa AT, Lee J, Parney IF, et al. Spinal cord and intradural-extraparenchymal spinal tumors: Current best care practices and strategies. J Neurooncol. 2004;69:291-318. Review

4 Gonzalez LF, Porter RW. Surgical technique for resection of intradural tumors. In: Kim DH, Henn JS, Vaccaro AR, et al, editors. Surgical Anatomy and Techniques to the Spine. Philadelphia: Elsevier Saunders; 2006:462-473.

5 Cantore G, Ciappetta P, Santoro A, et al. Discontinuous myelotomy: An alternative to standard myelotomy in the surgical treatment of intramedullary spinal cord tumours. Acta Neurochir (Wien). 2002;144:373-376.

6 Cho YJ, Kim SB, Chin DK, et al. Surgical treatment of intramedullary spinal cord cavernous malformation. Korean Neurosurg Soc. 2003;33:466-471.

7 Lee DK, Choe WJ, Chung CK, et al. Spinal cord hemangioblastoma: Surgical strategy and clinical outcome. J Neuro-oncology. 2003;61:27-34.

8 Neckrysh SN, Charbel FT, Lemole M. Vascular lesions of the spinal cord. In: Kim DH, Henn JS, Vaccaro AR, et al, editors. Surgical Anatomy and Techniques to the Spine. Philadelphia: Elsevier Saunders; 2006:474-488.

9 Cristante I, Herrmann HD. Surgical management of intramedullary hemangioblastoma of the spinal cord. Acta Neurochir (Wien). 1999;141:333-340.

10 Ogilvy CS, Louis DN, Ojemann RG. Intramedullary cavernous angiomas of the spinal cord: Clinical presentation, pathological features, and surgical management. Neurosurgery. 1992;31:219-229.

11 Spetzger U, Gilsbach JM, Bertalanffy H. Cavernous angiomas of the spinal cord clinical presentation, surgical strategy, and postoperative results. Acta Neurochir (Wien). 1995;134:200-206.